Lactoferrin for the Treatment of Rheumatoid Arthritis

Authors

  • Gargi Rajvanshi
  • Ritika Gupta

Abstract

Rheumatoid arthritis (RA) is a chronic systemic autoimmune disorder characterized by synovial hyperplasia that can lead to cartilage and bone erosion and is associated with decreased life expectancy and quality of life. In the last decade, various RA management strategies has been revolutionized which has led to discovery of specific treatments targeted against cytokines. Despite all available therapeutic approaches, only 20% of patients have reached remission and still many questions related to pathogenesis of RA are unanswered. Therefore, there is an urgent need to develop some novel antirheumatic therapies for RA treatment. Lactoferrin (Lf) is a ubiquitous protein which belongs to transferrin family and its concentration can significantly increased at the sites of inflammation. Recent reports have suggested that it may have anti-inflammatory and pro-inflammatory effects within the rheumatoid joint. Lf has shown to have therapeutic potential in mice with collagen-induced arthritis (CIA) after intra-articular injection. This study focusses on anti-inflammatory effects of lactoferrin for the treatment of rheumatoid arthritis.

 

Keywords: Rheumatoid arthritis, lactoferrin, collagen-induced arthritis, cytokines

Cite this Article

Gargi Rajvanshi, Ritika Gupta. Lactoferrin for the Treatment of Rheumatoid Arthritis. Research & Reviews: Journal of Dairy Science and Technology. 2019; 8(1): 6–9p.

Downloads

Published

2019-06-29

Issue

Vol. 8 No. 1 (2019)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.